FDA
approval
· 2019-08-26
FDA Approved: NITISINONE — Original Application (Endo USA, Inc.)
Summary
FDA approved an original application for nitisinone (Endo USA, Inc.), a generic version of nitisinone for hereditary tyrosinemia type I.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NITISINONE (NITISINONE)